Glycodeoxycholate (Sodium)

CAT:
804-HY-N1427-01
Size:
100 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Glycodeoxycholate (Sodium) - image 1

Glycodeoxycholate (Sodium)

  • Description:

    Glycodeoxycholate Sodium (Sodium glycyldeoxycholate) is a bile salt. Glycodeoxycholate Sodium has cytotoxicity to cancer cell, changes the permeability of the pancreatic duct and decreases glucose levels[1][2][3].
  • Product Name Alternative:

    Sodium glycyldeoxycholate
  • UNSPSC:

    12352211
  • Hazard Statement:

    H302, H312, H332
  • Target:

    Endogenous Metabolite
  • Type:

    Natural Products
  • Related Pathways:

    Metabolic Enzyme/Protease
  • Applications:

    Metabolism-protein/nucleotide metabolism
  • Field of Research:

    Metabolic Disease
  • Assay Protocol:

    https://www.medchemexpress.com/Glycodeoxycholate_Sodium.html
  • Purity:

    99.92
  • Solubility:

    DMSO : 125 mg/mL (ultrasonic; warming; heat to 60°C) |H2O : 100 mg/mL (ultrasonic)
  • Smiles:

    O=C (O[Na]) CNC (CC[C@@H] (C) [C@H]1CC[C@@]2 ([H]) [C@]3 ([H]) CC[C@]4 ([H]) C[C@H] (O) CC[C@]4 (C) [C@@]3 ([H]) C[C@H] (O) [C@]12C) =O
  • Molecular Formula:

    C26H42NNaO5
  • Molecular Weight:

    471.61
  • Precautions:

    H302, H312, H332
  • References & Citations:

    [1]Brayden DJ, et al. Sodium glycodeoxycholate and sodium deoxycholate as epithelial permeation enhancers: in vitro and ex vivo intestinal and buccal bioassays. Eur J Pharm Sci. 2021 Apr 1;159:105737.|[2]Farmer RC, et al. Effects of bile salts on permeability and morphology of main pancreatic duct in cats. Dig Dis Sci. 1984 Aug;29 (8) :740-51. |[3]Illum L, et al. Bioadhesive starch microspheres and absorption enhancing agents act synergistically to enhance the nasal absorption of polypeptides. Int J Pharm. 2001 Jul 3;222 (1) :109-19.
  • Shipping Conditions:

    Room Temperature
  • Storage Conditions:

    4°C (Powder, sealed storage, away from moisture)
  • Scientific Category:

    Natural Products
  • Clinical Information:

    No Development Reported
  • Isoform:

    Human Endogenous Metabolite; Microbial Metabolite
  • CAS Number:

    16409-34-0